Clinical trials
Active, not recruiting Neoplasms trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2022 | 1 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 5 |
| Exelixis | 2 |
| Novartis Pharmaceuticals | 2 |
| The University of Hong Kong | 2 |
| AbbVie | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| National Hospital Organization Nagoya Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma | 2 |
| Carcinoma, Renal Cell | 2 |
| Colonic Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Adenocarcinoma, Clear Cell | 1 |
| Anus Neoplasms | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.